Lazard Ltd. (LAZ) Reports In-Line Q2 EPS, Revenues Beat Expectations
Tweet
Share
E-mailGet Alerts LAZ Hot Sheet
Price: $45.21 -0.62%
Financial Fact:
Fund administration and outsourced services: 17.1M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Fund administration and outsourced services: 17.1M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
Lazard Ltd. (NYSE: LAZ) reported Q2 EPS of $0.48, in-line with the analyst estimate of $0.48. Revenue for the quarter came in at $500.6 million versus the consensus estimate of $470.1 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Lazard AUM rises to $286.9 billion at end of July 2026
- Acurx Pharmaceuticals (ACXP) Tops Q2 EPS by 4c
- Neumora Therapeutics, Inc. (NMRA) Tops Q2 EPS by 4c
Create E-mail Alert Related Categories
EarningsRelated Entities
LazardSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
